Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Review article: Description and management of fatigue in inflammatory bowel disease.

Czuber-Dochan W, Ream E, Norton C.

Aliment Pharmacol Ther. 2013 Mar;37(5):505-16. doi: 10.1111/apt.12205. Epub 2013 Jan 13. Review.

2.

Interventions for fatigue and weight loss in adults with advanced progressive illness.

Payne C, Wiffen PJ, Martin S.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2. Review.

PMID:
22258985
3.

Specialist nursing interventions for inflammatory bowel disease.

Belling R, McLaren S, Woods L.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006597. doi: 10.1002/14651858.CD006597.pub2. Review.

PMID:
19821376
4.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
5.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

6.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
7.

Natalizumab for induction of remission in Crohn's disease.

Macdonald JK, McDonald JW.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006097. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD006097.

PMID:
16856112
8.

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.

Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H, Rudwaleit M, Sieper J.

Arthritis Rheum. 2007 May 15;57(4):639-47. Review.

9.

Natalizumab for induction of remission in Crohn's disease.

MacDonald JK, McDonald JW.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. Review.

PMID:
17253580
10.

[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].

Ochsenkühn T, Sackmann M, Göke B.

Radiologe. 2003 Jan;43(1):1-8. Review. German.

PMID:
12552369
11.

Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.

Barrie A, Regueiro M.

Inflamm Bowel Dis. 2007 Nov;13(11):1424-9. Review.

PMID:
17567879
12.

Psychological interventions for treatment of inflammatory bowel disease.

Timmer A, Preiss JC, Motschall E, Rücker G, Jantschek G, Moser G.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006913. doi: 10.1002/14651858.CD006913.pub2. Review.

PMID:
21328288
13.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
14.

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease.

Anderson JL, Edney RJ, Whelan K.

Aliment Pharmacol Ther. 2012 Sep;36(6):503-16. doi: 10.1111/j.1365-2036.2012.05220.x. Epub 2012 Jul 25. Review.

15.

The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.

Lin MV, Blonski W, Buchner AM, Reddy KR, Lichtenstein GR.

Dig Dis Sci. 2013 Apr;58(4):1149-56. doi: 10.1007/s10620-012-2457-0. Epub 2012 Nov 20. Review.

PMID:
23179145
16.

Biological therapy of inflammatory bowel disease.

Owczarek D, Cibor D, Szczepanek M, Mach T.

Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):84-8. Review.

17.

Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease.

Bultman E, Kuipers EJ, van der Woude CJ.

Aliment Pharmacol Ther. 2010 Aug;32(3):313-23. doi: 10.1111/j.1365-2036.2010.04373.x. Epub 2010 May 22. Review.

18.

Anti-TNF therapy in inflammatory bowel diseases: a huge review.

Peyrin-Biroulet L.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):233-43. Review.

PMID:
20485259
19.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
20.

A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, Sampat S, Mendizabal M, Lin MV, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2011 Jan;9(1):36-41.e1. doi: 10.1016/j.cgh.2010.09.016. Epub 2010 Oct 1. Review.

PMID:
20888436
Items per page

Supplemental Content

Write to the Help Desk